Gabapentin in the management of pentazocine dependence: a potent analgesic--anticraving agent.
Article
Dans Anglais
| IMSEAR
| ID: sea-94001
ABSTRACT
OBJECTIVES:
To evaluate the role of Gabapentin in the management of Pentazocine dependence for suppressing muscle aching and craving during its withdrawal. MATERIAL ANDMETHODS:
Patients of Pentazocine dependence were divided in two groups GpA and GpB (n = 10 in each) and were administered Clonidine (P.O.) in first seven days (acute detoxification phase) and later Naltrexone (P.O.) from seventh day onwards (stabilisation-maintenance phase). Gabapentin (1200 mg/day) was additionally added in group B. Muscle pain and craving were rated on 100 mm visual-analogue scale. Psychological dependence was assessed on four step categorical scale.RESULTS:
Group B (Gabapentin group) scored significantly lower (p < 0.001) than group A on both the parameters. Psychological dependence was significantly low (p < 0.01) in Gabapentin group.CONCLUSION:
Gabapentin is an important adjuvant to the management of opiate dependence both in acute detoxification as well as stabilisation phase.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Douleur
/
Pentazocine
/
Syndrome de sevrage
/
Anxiolytiques
/
Femelle
/
Humains
/
Mâle
/
Clonidine
/
Troubles liés à une substance
/
Acides cyclohexanecarboxyliques
Type d'étude:
Essai clinique contrôlé
langue:
Anglais
Année:
2003
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS